NCT05905419View on ClinicalTrials.gov

Neuroimaging of Opioid Phase (OPAL)

NARecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Chronic PainOpioid Use
Interventions
OTHER

Opioid Phase

"Opioid-taking patients are assigned to take their prescribed opioid medication before (peak opioid phase) during 1 scan and after (trough opioid phase) during the other MRI scan"

Trial Locations (1)

27710

RECRUITING

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Duke University

OTHER

NCT05905419 - Neuroimaging of Opioid Phase (OPAL) | Biotech Hunter | Biotech Hunter